1. World Health Organisation: Global tuberculosis control - epidemiology, strategy, financing. WHO Report. 2009, Accessed 19 November 2009, [
http://www.who.int/tb/publications/global_report/2009/en/index.html
] WHO/HTM/TB/2009.411
2. Lukoye D, Cobelens F, Ezati N, Kirimunda S, Adatu F, Konde J, Joloba M: Anti-tuberculosis drug resistance in Kampala, Uganda, has not changed and shows no association with HIV infection. The 27th Uganda Medical Laboratory Technology Association Scientific Conference, Kabale, Uganda. 2009
3. World Health Organisation: Policy Statement. Molecular Line Probe Assays for Rapid Screening of patients at risk of multidrug resistant tuberculosis (MDR-TB), 2008. Accessed 18 November 2009, [
http://www.who.int/tb/dots/laboratory/lpa_policy.pdf
]
4. Ling D, Zwerling A, Pai M: GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008, 32: 1165-1174. 10.1183/09031936.00061808.
5. World Health Organisation: Use of Liquid TB culture and drug susceptibility testing (DST) in low- and medium- income settings. 2007, Accessed 18 November 2009, [
http://www.who.int/tb/dots/laboratory/policy/en/index3.html
]